Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Global CA Tumor Markers Testing Market to Witness Remarkable Growth Owing to the Increasing Rate of Incidence of Cancer during the Forecast Period 2016 – 2023

Press release Description

Albany, New York, April 28, 2017: The CA (cancer antigen) tumor marker testing is a lucrative market, thanks to the rising rate of incidence of cancer and high numbers of patients opting for this testing procedure. A new research report titled as “CA Tumor Markers Testing Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2023” has been added to the vast portfolio of Market Research Reports Search Engine (MRRSE). This report studies global CA tumor markers testing market and researches its current and future prospect.

The report has been compiled through extensive primary research (surveys, interviews and observations of researchers) and secondary research (industry journals, reliable paid sources and industrial databases and reports). Moreover, it also provides a complete qualitative and quantitative assessment by analyzing documents gathered from market participants and industrial analysts across major points in the market’s value chain mechanism. The study also analyzes the ongoing trends in the market, along with macro- and micro-economic pointers and regulations. Moreover, predictions regarding the CA tumor marker testing market’s tremendous growth owing to the increasing prevalence of cancer and other non-communicable diseases can be carefully checked out in the report. Moreover, rising geriatric population will further power the growing demand for tumor testing globally. On the other hand, increase in healthcare spending, rigid and unfavorable reimbursement policies and the high cost of developing new technologies are the factors that can hamper growth of the CA tumor marker testing market.

The global CA tumor markers testing market is segmented on the basis of key parameters such as technology, type and geography. The major technologies used for the detection of CA tumor markers are as follows:

  • Enzyme Immunoassays (EIA)
  • Latex Agglutination
  • Radioimmunoassay (RIA)
  • PCR
  • Immuno-PCR
  • Nucleic acid sequence based amplification (NASBA)

Based on type of CA (cancer antigen) marker, the market is divided into the following:

  • Cancer Antigen 27-29 (CA 27-29), used for detecting breast cancer
  • Cancer Antigen 125 (CA 125), used for detecting epithelial ovarian cancer
  • Cancer Antigen 19-9 (CA 19-9), used for detecting colorectal cancer
  • Cancer Antigen 15-3 (CA 15-3), used for detecting breast cancer

Browse Full Global CA Tumor Markers Testing Market Report with TOC :

The global CA tumor markers testing market is highly fragmented due to the participation of many players both emerging and established. The key players operating in the CA tumor markers testing market are Abbott Laboratories, Dickinson and Company, Becton, Applied Genetic Technologies Corporation, bioMérieux SA, Correlogic Systems Inc., Cepheid, Myriad Genetics, Panacea Pharmaceuticals, Radient Pharmaceuticals, Qiagen, Siemens Healthcare, Targeted Diagnostics & Therapeutics and Thermo Fisher Scientific.

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559